SGLT2 inhibitors in older adults: overcoming the age barrier.

dc.contributor.author	Bellary, Srikanth
dc.contributor.author	Barnett, Anthony H
dc.date.accessioned	2023-06-19T10:41:24Z
dc.date.available	2023-06-19T10:41:24Z
dc.date.issued	2023-04-04
dc.identifier.citation	Bellary S, Barnett AH. SGLT2 inhibitors in older adults: overcoming the age barrier. Lancet Healthy Longev. 2023 Apr;4(4):e127-e128. doi: 10.1016/S2666-7568(23)00039-9.	en_US
dc.identifier.eissn	2666-7568
dc.identifier.doi	10.1016/S2666-7568(23)00039-9
dc.identifier.pmid	37003269
dc.identifier.uri	http://hdl.handle.net/20.500.14200/1023
dc.description.abstract	No abstract available	en_US
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.relation.url	https://www.thelancet.com/journals/lanhl/home	en_US
dc.subject	Endocrinology	en_US
dc.title	SGLT2 inhibitors in older adults: overcoming the age barrier.	en_US
dc.type	Article
dc.source.journaltitle	The Lancet Healthy Longevity
dc.source.volume	4
dc.source.issue	4
dc.source.beginpage	e127
dc.source.endpage	e128
dc.source.country	England
rioxxterms.version	NA	en_US
dc.contributor.trustauthor	Bellary, Srikanth
dc.contributor.trustauthor	Barnett, Anthony H
dc.contributor.department	General Medicine	en_US
dc.contributor.role	Medical and Dental	en_US
oa.grant.openaccess	na	en_US

Name:

Publisher version